Development Services Agreement Sample Contracts

Research and Development Services Agreement (August 14th, 2018)

This Agreement is made and entered into as of this 8th day of August, 2018 by and between Vicon Industries, Inc., having a principal place of business at 135 Fell Court, Hauppauge, New York (hereinafter referred to as "Vicon" or "Parent") and Cemtrex, Inc., having a principal place of business at 19 Engineers Lane, Farmingdale, New York 11735, and its subsidiaries. (hereinafter referred to as "Cemtrex").

Forex Development Corp. – Information Technology & Software Development Services Agreement (June 25th, 2018)

This Information Technology & Software Services Agreement ("Agreement") is made this 5th day of February 2018 (the "Effective Date") between Forex Development Corporation, a Delaware Corporation, located at 1460 Broadway, New York, NY ("the Company"), and NSFX Ltd. with a principle office at 168 St Christopher Street, Valletta VLT 1467, MALTA ("Customer"), Registration Number: C/56519 MFSA License Number: IS/56519.

Forex Development Corp. – Information Technology & Software Development Services Agreement (May 17th, 2018)

This Information Technology & Software Services Agreement ("Agreement") is made this 5th day of February 2018 (the "Effective Date") between Forex Development Corporation, a Delaware Corporation, located at 1460 Broadway, New York, NY ("the Company"), and NSFX Ltd. with a principle office at 168 St Christopher Street, Valletta VLT 1467, MALTA ("Customer"), Registration Number: C/56519 MFSA License Number: IS/56519.

Provention Bio, Inc. – CONFIDENTIAL TREATMENT REQUESTED: Certain Portions of This Document Have Been Omitted Pursuant to a Request for Confidential Treatment And, Where Applicable, Have Been Marked With an Asterisk ("[*****]") to Denote Where Omissions Have Been Made. The Confidential Material Has Been Filed Separately With the Securities and Exchange Commission. DEVELOPMENT SERVICES AGREEMENT BETWEEN the Institute for Translational Vaccinology ("Intravacc") AND Provention Bio, Inc. ("Provention") (May 16th, 2018)

The State of the Netherlands, represented by the Minister of Public Health, Welfare and Sports, on behalf of the Minister, Projectdirectie ALT, The Institute for Translational Vaccinology (Intravacc), having its offices at Antonie van Leeuwenhoeklaan 9, 3721 MA Bilthoven, The Netherlands, legally represented by its General Director [****], hereinafter referred to as "Intravacc";

Grey Cloak Tech Inc. – Development Services Agreement (May 25th, 2017)

This Development Services Agreement (this "Agreement") is entered into effective April 1, 2017 (the "Effective Date") by and between Grey Cloak Tech Inc., a Nevada corporation (the "Company") and Dimicho Pty. Ltd. ("Developer"), having its principal place of business at 198 Harbour Esplanade, Docklands Vic Australia, 3000.

Grey Cloak Tech Inc. – Development Services Agreement (May 25th, 2017)

This Development Services Agreement (this "Agreement") is entered into effective March 31, 2017 (the "Effective Date") by and between Grey Cloak Tech Inc., a Nevada corporation (the "Company") and Covely Information Systems ("Developer"), having its principal place of business in Carlsbad, California.

Foresight Autonomous Holdings Ltd. – Software Development Services Agreement Made and Entered Into in Tel Aviv on the 5th of January, 2016, (Hereinafter: The "Agreement") (May 11th, 2017)

Between: MAGNA - B.S.P. Ltd. Company number: 513066639 Henri Malka Street, Dimona (hereinafter: the "Company") On the One Part And Between: Four Eyes Autonomous Ltd. Company number: 515287480 Henri Malka Street, Dimona (hereinafter: the "Customer") On the Second Part

Foresight Autonomous Holdings Ltd. – Software Development Services Agreement Made and Entered Into in Tel Aviv on the 5th of January, 2016, (Hereinafter: The "Agreement") (February 23rd, 2017)

Between: MAGNA - B.S.P. Ltd. Company number: 513066639 Henri Malka Street, Dimona (hereinafter: the "Company") On the One Part And Between: Four Eyes Autonomous Ltd. Company number: 515287480 Henri Malka Street, Dimona (hereinafter: the "Customer") On the Second Part

VivoPower International PLC – Development Services Agreement (August 24th, 2016)
Indivior Plc – Research and Development Services Agreement (August 1st, 2016)
ONCOSEC MEDICAL Inc – Research and Development Services Agreement (July 1st, 2016)

THIS RESEARCH AND DEVELOPMENT SERVICES AGREEMENT ("Agreement") is being entered into as of this 6th day of March, 2015 (the "Effective Date"), by and between OncoSec Medical Incorporated, a Nevada Corporation with a principal place of business at 9810 Summers Ridge Rd., Ste. 110, San Diego, CA 92121 (the "Company"), and Rev.1 Engineering Inc., a California Corporation, having a principal place of business at 41693 Date Street, Murrieta, CA 92562 ("Rev.1"). Rev.1 and Company are at times referred to individually as a "Party" and jointly as the "Parties."

ONCOSEC MEDICAL Inc – Amendment No. 1 to Research and Development Services Agreement (July 1st, 2016)

This Amendment No. 1 to Research and Development Services Agreement (this "Amendment") dated as of February 17th, 2016 (the "Amendment Date") is entered into between OncoSec Medical Incorporated, a Nevada corporation (hereinafter, "Company"), having offices at 5820 Nancy Ridge Drive, San Diego, California 92121, and Rev.1 Engineering Inc., a California corporation (hereinafter, "Rev.1"), having offices at 41693 Date Street, Murrieta, California 92562, with respect to the following facts:

Key Link Assets Corp. – Business Development Services Agreement (June 10th, 2016)

THIS BUSINESS DEVELOPMENT SERVICES AGREEMENT (the "Agreement") is entered into by and among Wilshire Energy Partners, Aegis International and Foothills Petroleum, Inc., a Nevada corporation ("Foothills") with a reference to the following:

Bluerock Residential Growth REIT, Inc. – Development Services Agreement (February 24th, 2016)

THIS DEVELOPMENT SERVICES AGREEMENT (this "Agreement") is made as of November 20, 2015, by and between BRG Domain Phase 1 Development Manager, LLC, a Delaware limited liability company ("Development Manager") and BR - ArchCo Domain Phase 1, LLC, a Delaware limited liability company ("Owner").

ONCOSEC MEDICAL Inc – Amendment No. 1 to Research and Development Services Agreement (January 26th, 2016)

THIS AMENDMENT NO. 1 TO RESEARCH AND DEVELOPMENT SERVICES AGREEMENT (this "Amendment") dated as of September 23, 2015 (the "Amendment Date"), is entered into between OncoSec Medical Incorporated, a Nevada corporation (hereinafter, "Company"), having offices at 9810 Summers Ridge Road, Suite 110, San Diego, California 92121, and Merlin CSI, LLC, a California limited liability company (hereinafter, "Merlin"), having offices at 13135 Danielson Street #212, Poway, California 92064, with respect to the following facts:

ONCOSEC MEDICAL Inc – Research and Development Services Agreement (January 26th, 2016)

THIS RESEARCH AND DEVELOPMENT SERVICES AGREEMENT ("Agreement") is being entered into as of this 6th day of March, 2015 (the "Effective Date"), by and between ONCOSEC MEDICAL INCORPORATED, a Nevada Corporation with a principal place of business at 9810 Summers Ridge Rd., Ste. 110, San Diego, CA 92121 (the "Company"), and MERLIN CSI, LLC., a California Limited Liability Company, having a principal place of business at 13135 Danielson Street, #212, Poway, CA 92064 ("Merlin"). Merlin and Company are at times referred to individually as a "Party" and jointly as the "Parties."

Kitov Pharmaceuticals Holdings Ltd. – Development Services agreEment (September 24th, 2015)

This Development Services Agreement (the "Agreement"), is made and entered into, as of ________________, 2014, by and between Kitov Pharmaceuticals Holdings Ltd., an Israeli company with offices at Lev Hagiva, 11 Bet Hadfus Street, Jerusalem 95483, Israel (hereinafter "Kitov"); and Dexcel Ltd., a company incorporated under the laws of Israel, with offices at 1 Dexcel Street Or Akiva, 3060000, Israel ("Dexcel").

Kitov Pharmaceuticals Holdings Ltd. – Development Services agreEment (August 21st, 2015)

This Development Services Agreement (the "Agreement"), is made and entered into, as of ________________, 2014, by and between Kitov Pharmaceuticals Holdings Ltd., an Israeli company with offices at Lev Hagiva, 11 Bet Hadfus Street, Jerusalem 95483, Israel (hereinafter "Kitov"); and Dexcel Ltd., a company incorporated under the laws of Israel, with offices at 1 Dexcel Street Or Akiva, 3060000, Israel ("Dexcel").

Addendum to the Master Staff Augmentation and Application Development Services Agreement; Master Service Agreement Dated September 30, 2008; And Master Service Agreement Dated January 23, 2009 (August 4th, 2015)

This Addendum to the Master Staff Augmentation and Application Development Services Agreement dated May 3, 2006, the Master Services Agreement dated September 30, 2008 and the Master Services Agreement dated January 23, 2009 ("Addendum"), made July 1, 2015 ("Addendum Effective Date") by and between Cognizant Technology U.S. Corporation ("Supplier") and Health Net, Inc. ("Health Net"), modifies each of the foregoing agreements. In the event of a conflict between this Addendum and any of the foregoing agreements, this Addendum will prevail.

Discovery Laboratories, Inc. – Amendment to Research and Development Services Agreement (May 11th, 2015)

Effective as of May 7, 2015, Battelle Memorial Institute and Discovery Laboratories, Inc. hereby agree to amend the Research and Development Services Agreement between them dated as of June 22, 2012 (as it may have been previously amended, the "Agreement") to reflect the revisions set forth herein. Capitalized terms used herein and not otherwise defined shall have the meanings ascribed to such terms as set forth in the Agreement.

Amended and Restated Intellectual Property License and Development Services Agreement Between Upmc and Evolent Health, Inc. Effective From June 27, 2013 (May 5th, 2015)

THIS AMENDED AND RESTATED INTELLECTUAL PROPERTY LICENSE AND DEVELOPMENT SERVICES AGREEMENT (the Agreement) is made and entered into effective as of June 27, 2013 (the Effective Date), by and between UPMC, a Pennsylvania nonprofit corporation (UPMC), and Evolent Health, Inc., a Delaware corporation (Evolent) (each a Party, collectively, Parties).

To Development Services Agreement (April 13th, 2015)

This Amendment No. 1 to Development Services Agreement (the "Amendment") is dated as of April 1, 2014 (the "Effective Date"), is between ACHAOGEN, INC. ("Achaogen") and ARK Diagnostics, Inc. ("Ark") and is issued pursuant to the Development Services Agreement (the "Agreement") dated August 19, 2013, by and between Achaogen and Ark who are sometimes hereinafter jointly referred to as the "Parties" to this Amendment.

ONCOSEC MEDICAL Inc – Research and Development Services Agreement (March 11th, 2015)

THIS RESEARCH AND DEVELOPMENT SERVICES AGREEMENT (Agreement) is being entered into as of this 6th day of March, 2015 (the Effective Date), by and between ONCOSEC MEDICAL INCORPORATED, a Nevada Corporation with a principal place of business at 9810 Summers Ridge Rd., Ste. 110, San Diego, CA 92121 (the Company), and MERLIN CSI, LLC, a California Limited Liability Company, having a principal place of business at 13135 Danielson Street, #212, Poway, CA 92064 (Merlin). Merlin and Company are at times referred to individually as a Party and jointly as the Parties.

ONCOSEC MEDICAL Inc – Research and Development Services Agreement (March 11th, 2015)

THIS RESEARCH AND DEVELOPMENT SERVICES AGREEMENT (Agreement) is being entered into as of this 6th day of March, 2015 (the Effective Date), by and between ONCOSEC MEDICAL INCORPORATED, a Nevada Corporation with a principal place of business at 9810 Summers Ridge Rd., Ste. 110, San Diego, CA 92121 (the Company), and REV.1 ENGINEERING INC., a California Corporation, having a principal place of business at 41693 Date Street, Murrieta, CA 92562 (Rev.1). Rev.1 and Company are at times referred to individually as a Party and jointly as the Parties.

Replidyne, Inc. – Development Services Agreement (August 28th, 2014)

THIS DEVELOPMENT SERVICES AGREEMENT ("Agreement") is made this 11th day of June, 2014, between RYAN COMPANIES US, INC., a Minnesota corporation ("Ryan"), and CARDIOVASCULAR SYSTEMS, INC., a Delaware corporation ("CSI").

Enertopia Corp. – Marihuana Project Development Services Agreement (March 11th, 2014)

Matthew Chadwick 10682 244th StMaple Ridge BC V2W 2E6 (Hereinafter referred to as Provider or Chadwick) AND: Enertopia Corp. 950 - 1130 Pender St WVancouver BC Canada V6E 4A4 Kelowna BC V1X 7W2

Development Services Agreement (February 27th, 2014)

This Development Services Agreement (this Agreement), effective as of August 19, 2013 (the Effective Date), is made by and between Achaogen Inc. (Achaogen), a corporation with offices at 7000 Shoreline Court, Suite 371, South San Francisco, California 94080, and ARK Diagnostics, Inc. (Ark), a corporation with offices at 48089 Fremont Boulevard, Fremont, California 94538 (each a Party, and collectively the Parties).

Dipexium Pharmaceuticals, Inc. – Research & Development Services Agreement Dpt Laboratories, Ltd and Dipexium Pharmaceuticals, Llc (February 6th, 2014)

This Research & Development Services Agreement (the Agreement) is made as of this 8th. day of December, 2011 by and between Dipexium Pharmaceuticals, LLC a corporation organized under the laws of the State Of Delaware, with its principal place of business at (hereinafter referred to as COMPANY) and DPT Laboratories, Ltd., a Texas Limited Partnership, with its principal place of business at , including its affiliate DPT Lakewood, LLC. (hereinafter referred to as DPT).

Development Services Agreement (January 24th, 2014)

This Development Services Agreement (this Agreement), effective as of August 19, 2013 (the Effective Date), is made by and between Achaogen Inc. (Achaogen), a corporation with offices at 7000 Shoreline Court, Suite 371, South San Francisco, California 94080, and ARK Diagnostics, Inc. (Ark), a corporation with offices at 48089 Fremont Boulevard, Fremont, California 94538 (each a Party, and collectively the Parties).

Enertopia Corp. – Corporate Development Services Agreement (January 13th, 2014)

Company hereby engages Provider to provide corporate development services and hereby retains and engages Provider on the terms and conditions of this Agreement. Provider accepts such appointment and agrees to use its best efforts to perform such services, upon the terms and conditions of this Agreement.

Software Development Services Agreement by and Between Globoforce Limited and EPAM Systems Limited (November 8th, 2013)
CNL Healthcare Properties, Inc. – Development Services Agreement (September 5th, 2013)

This Development Services Agreement (Agreement) is made and entered into as of the 19th day of August, 2013, by and between CHP RAIDER RANCH TX SENIOR HOUSING OWNER, LLC, a Delaware limited liability company (Owner), and SOUTH BAY PARTNERS, LTD., a Texas limited partnership (South Bay).

Coronus Solar Inc. – Share Purchase and Development Services Agreement (August 15th, 2013)

CORONUS SOLAR INC., a company incorporated under the laws of Canada and having a registered office at 1600 - 609 Granville Street, Vancouver, British Columbia, V7Y 1C3

Coronus Solar Inc. – Entry Into Share Purchase and Development Services Agreement Extension of Loan Maturity Date (August 15th, 2013)

Vancouver, B.C. - August 15, 2013 - Jeff Thachuk, President of Coronus Solar Inc. (the "Company") announced today that, on August 9, 2013, the Company and its wholly-owned subsidiary, Coronus Energy Corp. ("Coronus"), entered into a share purchase and development services agreement (the "Share Purchase and Development Services Agreement") with Redwood Solar Development LLC ("Redwood").

Teekay Lng Partners Lp – 1st January 2012 TEEKAY LNG OPERATING LLC -And- TEEKAY SHIPPING LIMITED BUSINESS DEVELOPMENT SERVICES AGREEMENT (April 16th, 2013)